Chapters

Transcript

Video

How do you recommend managing the patient who has a major CV/thrombotic event—a recent MI—who is on a statin and has an LDL-C level of 60-70 mg/dL? How does the ODYSSEY Outcome Trial and/or IVUS studies help you assess the role of a PCSK9 inhibitor?

How do you recommend managing the patient who has a major CV/thrombotic event—a recent MI—who is on a statin and has an LDL-C level of 60-70 mg/dL? How does the ODYSSEY Outcome Trial and/or IVUS studies help you assess the role of a PCSK9 inhibitor? 

 


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Rosenson, MD

Robert Rosenson, MD

Professor of Medicine (Cardiology)
Mount Sinai Icahn School of Medicine
Director, Cardiometabolics Unit
Mount Sinai Heart Institute
New York, NY